Definium Therapeutics DFTX
NASDAQ DFTX
$35.51 +0.42 (+1.18%)
As of: Oct 21, 2026 · 9:36 AM EDT

Definium Therapeutics (DFTX) Revenue (2021 - 2023)

Updated

Analysis

Definium Therapeutics (DFTX) Revenue (2021 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,134.42 Bn 1,103.01 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 619.36 Bn 537.89 Bn 17.26 Bn 25.31 Bn
3 AbbVie 510.11 Bn 483.22 Bn 12.70 Bn 16.99 Bn
4 Merck 365.37 Bn 319.75 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.64 Bn 261.63 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 262.52 Bn 236.21 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.62 Bn 192.02 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 192.60 Bn 166.80 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn 15.03 Bn
10 Definium Therapeutics 3.93 Bn 1.85 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 905,000.00
Sep 30, 2023 1.16 Mn
Jun 30, 2023 1.31 Mn
Mar 31, 2023 1.28 Mn
Dec 31, 2022 1.05 Mn
Sep 30, 2022 360,000.00
Jun 30, 2022 82,000.00
Mar 31, 2022 -27,000.00
Dec 31, 2021 -139,000.00
Sep 30, 2021 -64,000.00
Jun 30, 2021 -69,000.00
Mar 31, 2021 -87,000.00
API Access

Definium Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=DFTX&period=max&api_key=YOUR_API_KEY